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Abstract
New cytometric techniques continue to push the boundaries of multi-parameter quantitative
data acquisition at the single-cell level particularly in immunology and medicine. Sophisti-
cated analysis methods for such ever higher dimensional datasets are rapidly emerging,
with advanced data representations and dimensional reduction approaches. However,
these are not yet standardized and clinical scientists and cell biologists are not yet experi-
enced in their interpretation. More fundamentally their range of statistical validity is not yet
fully established. We therefore propose a new method for the automated and unbiased anal-
ysis of high-dimensional single cell datasets that is simple and robust, with the goal of reduc-
ing this complex information into a familiar 2D scatter plot representation that is of
immediate utility to a range of biomedical and clinical settings. Using publicly available flow
cytometry and mass cytometry datasets we demonstrate that this method (termed CytoBin-
ning), recapitulates the results of traditional manual cytometric analyses and leads to new
and testable hypotheses.
Introduction
Cytometry is a multi-parameter single-cell measurement technique that is widely used in bio-
logical and clinical studies [1–6]. One of the main uses of flow cytometry, which has had a
major impact across the fields of immunology and medicine, is to differentiate immune cells
compositions among cell types or patients. Modern flow cytometers can routinely measure
15–20 cellular markers on millions of cells from dozens of samples in one experiment, and can
sort cells into subpopulations based on those markers. Recently mass cytometry has expanded
the number of markers that can be measured simultaneously to 100, though the technique is
destructive to cells and does not allow for sorting. The conventional way of analyzing flow
cytometry data uses a gating strategy which requires the manual selection of regions of interest
(ROI) on sequential 2D scatterplots. This type of analysis is very labor intensive and inefficient
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for such large datasets and also suffers from subjectivity in both the sequence of 2D scatterplots
and selection of thresholds (ROI) [3,4,7–10]. Therefore, as both the number of cells analyzed
and the number of markers quantified for each cell have grown over the past decade, novel
automated and unbiased analysis methods for flow cytometry data are emerging [11].
These novel analysis methods can be divided into two categories based on the problem they
address: 1) methods trying to mimic and automatize the process of manual gating [12–18];
and 2) methods trying to identify cell populations using all markers simultaneously without
prior biological knowledge [19–22]. Some cutting-edge approaches to automating manual gat-
ing, such as flowDensity [16], are very successful in re-identifying cell subsets that match with
manually gated subsets in an automatic, reproducible way. However, gating (both manual and
automatic) relies heavily on prior experience to inform the sequence of markers to gate. Fur-
thermore, in gating, researchers must define the cell phenotypes to look for in advance of their
analysis, hence hindering discovery of novel cell types and not tapping into the full potential of
the acquired data. Gating methods also only explore a very limited portion of the total data
space, though unsupervised methods have been published that enhance the efficiency of data
usage, with the potential to reveal otherwise hidden differences between datasets [23]. Most
unsupervised methods that allow novel cell type discovery aim to identify regions with high
cell density in multi-dimensional space [19,21,23–30]. This assumes cells form distinct pheno-
types and that only cells inside those relative high-density areas (peaks) are of importance.
However, cells that are in between two high-density clusters (valleys) may also have potential
biological significance [31]. Another limitation of clustering based methods is that concatenat-
ing different samples (which is a widely used strategy [28,32]) with potential batch effects can
be problematic, hence limiting the meaningful combination datasets across institutions (which
is very common in clinical trials). In addition, these clustering based methods require estima-
tion of nearest neighbors in high-dimensional space which suffers from “curse of dimensional-
ity” and may lead to misleading results [33]. As a result, people have been calling for the use of
lower dimensional methods such as gating based on 2D scatterplots [34].
In this paper, we present a new method for analyzing cytometry data that utilizes such 2D
scatter plots. Instead of gating, we dig deeper into the scatter plots mining the information that
are largely bypassed by other methods. This method is useful for the majority of comparative
studies that aim to elucidate the difference between two groups of samples. Our method,
which we term CytoBinning, identifies the most information rich 2D scatter plots and extracts
biological insights from them. We show that biologically relevant differences can be discovered
from the pairs of markers identified with this approach. First, we introduce CytoBinning with
a synthetic dataset, and then apply it to two public high-dimensional single cell datasets, a flow
cytometry dataset comparing composition in immune cells between old and young healthy
human donors [21], and a mass cytometry dataset analyzing the immune signature of eight
types of human tissues [35].
Results
We synthesized two point-patterns based on the expression of two virtual markers: maker A
and marker B. Ten samples were generated for each point-pattern. The first point-pattern,
called pattern A, consists of three point-clusters. Two large clusters each contain 5,000 points
and a third relatively small cluster contains about 2,000 points. The three clusters are randomly
sampled from Gaussian distributions that centered at point (0, 4), (0, -4) and (4, 0) with stan-
dard deviation 2, 2, and 1 respectively. The second point-pattern, called pattern B, also consists
of three point-clusters. The two large clusters are generated in the same way as point-pattern
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A, however, the third smaller point-pattern only contains 200 to 500 points, sampled from a
Gaussian distribution centered at point (-4, 6) with standard deviation 1 (S1 Fig).
Percentile-based binning is a coarse-grained representation of point
patterns
An example of percentile-based binning is shown in Fig 1 using one synthetic sample with
point-pattern A. Points inside the point-pattern were first binned into 3 levels based on the
expression of marker A and B independently, each level containing one third of points. The 3
levels for marker A and B were then combined on a 2D scatter plot to form 9 sub-regions
(these sub-regions are called boxes). The percentage of points in each box changes depending
on the point-pattern. This binning method has been used as an alternative method to calculate
mutual information (MI) in a robust and computationally efficient way [36]. MI is a measure
of dependence between two random variables widely used in gene network inference [37] as a
general measure of interdependency between genes. In our method, instead of summarizing
the binning information into one number (MI), we used percentage of points in each box as a
Fig 1. An example of percentile-based binning as a representation of 2D point-pattern (number of bins = 3). (A) Synthesized point-pattern formed by expression of
marker A and marker B. (B) Points are binned into 3 bins each containing 1/3 (33.3%) of the total points. The bins are labeled numerically based on the expression level
of the related marker, with 1 the lowest and 3 the highest (similarly if points are divided into 5 bins then the highest level is 5). This binning is done independently for
marker A and marker B based on their expression. (C) Bins obtained in (B) are combined so that 9 sub-regions referred as boxes are formed. The percentage of points
inside each box is calculated, and the matrix of percentages is straightened to a vector so that the 2D point-pattern shown in panel (A) is coarse-grained to the vector in
(D).
https://doi.org/10.1371/journal.pone.0205291.g001
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coarse-grained representation of point-patterns to obtain detailed information of point-
patterns.
Applying percentile-based binning to multiple samples enables meaningful
classification
After we demonstrate how to represent point-patterns with percentile-based binning, next we
show that this representation is able to capture real differences in point-patterns. Fig 2A shows
two examples of the synthetic point-patterns. In total, 10 samples were generated for each
point-pattern, and each sample was analyzed using percentile-based binning to generate the
row vectors shown in Fig 2B. Using 3 bins, our method is able to cluster the two point-patterns
into distinct groups, and correctly identifies the most significant difference (Fig 2B and 2C).
Boxplots of cell percentage in each box show that the box with most distinct difference
between the two point-patterns is box B32 which contains the third cluster of point-pattern A
(lower panel of Fig 2B, adjusted p value<< 0.001). This is the most significant difference
between these two point-patterns, and it was captured without referring to density distribution
of points. Minor differences between these two point-patterns (the small cluster located at the
top left corner) were not spotted, since the percentage of points in box B13 is similar in both
point patterns (Fig 2B). However, this third cluster in pattern B (~ 2% to 5%), was identified
when the number of bins was increased to 6 (S2 Fig). Hence, the depth of analysis depends on
the number of bins.
The maximum number of bins for binning depends on the number of
samples (patients)
We’ve seen in the previous section that the depth of analysis depends on the number of bins
used. And here we are going to show that the maximum number of bins we could use depends
on the total number of samples (patients), for using a large number of bins to classify a small
set of samples would cause overfitting. We see that false positive rate (FPR) increases with the
numbers of bins used for binning (Fig 3A). However, the maximum number of bins with toler-
able FPR (FPR < 0.05) increased when we increase the number of samples from 20 to 60 (Fig
3A). While with 20 samples we can only use as many as 3 bins to keep FPR under 0.05, with 60
samples this number increased to 6. And using 6 bins, our method is able to identify both of
the differences we artificially generated between point-pattern A and B (S3 Fig). To get a gen-
eral picture of how the maximum number of bins relates to number of samples, we calculated
the maximum number of bins with FPR = 0 (we use this stringent condition because i) Syn-
thetic data is easier to classify; ii) Real dataset contains more than 2 markers, and multiple tests
correction should be taken into consideration) for various number of samples. We found that
when the two groups to be classified contain the same number of samples (patients), the maxi-
mum number of bins is around the square root of half the sample size (Fig 3B). In reality, the
number of samples (patients) in different groups is rarely equal. However, we can overcome
this inequality by assigning different number of samples to cross validation set for different
groups so that in training dataset each group will have the same number of samples. Thus,
once we know the number of samples in training dataset, we get a reasonable estimate for the
number of bins to use.
Application to two real human cytometry datasets
Next, we applied our method to two real flow cytometry datasets. Both datasets aim to identify
differences between two biologically different patients/donor groups. In general, in order to
CytoBinning: Immunological insights from multi-dimensional data
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get rid of debris and dead cells, some pre-processing steps should be taken before applying our
method (e.g. manual/automatic gating to get live cells). In addition, depends on the question
of interest, further gating can be applied to get more focused cell types, e.g. T cells, CD4+ T
cells, etc. The pre-processed datasets are then the input for our method. We first determine the
appropriate number of bins to use based on the number of samples in a dataset. Next, we apply
the binning method showing in Fig 1 to the pre-processed dataset. Unlike the simulated data-
set showing above which only contains two markers, real cytometry datasets usually measure
much more markers which results in even more marker pairs. The binning method is applied
to every possible pairs of markers. Then, in order to identify the important marker pairs, we
separated the dataset into training and testing subsets. Using a classification algorithm called
support vector machine (SVM) [38], we define important marker pairs as the ones that are
able to achieve 100% classification accuracy in both training and testing subsets. Once these
marker pairs were determined, we move on to identify which regions formed by these marker
pairs (boxes) are significantly different between the two groups.
Old versus young. The first dataset we analyzed aims to find differences in the composi-
tion of immune cell types between old and young healthy donors [39]. Peripheral blood mono-
nuclear cell (PBMC) samples from 34 healthy old donors (ages 60 and above) and 22 healthy
Fig 2. Percentile based binning is able to detect real difference between point-patterns. (a) Example of the two synthesized point-
patterns A and B. The two large clusters in pattern A and B contain same number of cells and were generated with the same
distribution. Pattern A contains a relatively large third cluster (10% to 20% of cells) at center right of the pattern and pattern B
includes a smaller third cluster (2% to 5% of cells) on the top left corner. (b) Upper panel shows a heatmap of point percentage in
each box for all samples, and lower panel shows boxplots of point percentage in each box between the groups of point-patterns. (c)
Labels of each box. Highlighted is box B32.
https://doi.org/10.1371/journal.pone.0205291.g002
Fig 3. The maximum number of bins depends on the number of samples (patients). (A) Estimated false positive rate (FPR) vs number of bins for 20 samples (red)
and 60 samples (blue). The dotted black line represents FPR = 0.05. The number of bins that leads to a high FPR (>0.05) is considered overfitting the dataset. (B) The
maximum number of bins with FPR = 0 vs total number of samples used in the dataset. Blue dots show simulation results with our synthetic datasets and red dots shows
the estimated number of bins using the rule of thumb: maximum number of bins ¼ roundð
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
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young donors (ages 19 to 35) were taken, and their cellular composition were quantified by
flow cytometry. In total, 16 markers were measured: Ki67, CD95, CD127, CD57, CD3,
CD45RA, CD8, CD14, CCR4, CD27, CD11b, PD1, CD4, CD28, CCR7, and a viability dye
(live/dead). We first manually gated for the live cells (S4 Fig) which were used as input for our
method. At this stage, about 20% of samples (4 young samples and 6 old samples) were ran-
domly chosen as a cross validation set. We determined the optimal number of bins in remain-
ing training dataset to be 5 (as the total number of samples in training set is 46, Fig 3B), then
we applied SVM classification based on the binning results of all possible pairs of markers. In
total, we identified two pairs of markers (CD8—CCR7, CD3—CD4) that are able to classify
old and young donors with 100% accuracy both in training and testing dataset (S5 Fig). And
boxes whose cell percentages are significantly different between old and young donors are
identified. We selected the two boxes that are most different between old and young donors
for demonstration below, remaining results can be found in supplementary information (S6–
S8 Figs).
Naïve CD8+ T cells are found significantly decreased in elderly donors using only CD8
and CCR7 expression. We first look at box B55 which contains cells whose expression of
both CD8 and CCR7 are in the top 20% (i.e. CD8high CCR7high, Fig 4A). We find that percent-
age of cells inside box B55 decrease significantly in old donors (Fig 4B, adjusted p value <<
0.001). On the other hand, mean fluorescence intensity (MFI) of cells inside box B55 are simi-
lar among donors for all markers, indicating cells inside box B55 are homogeneous across all
samples (Fig 4C). Notice that CD3 and CD45RA MFI levels are high for all samples, and since
cells inside box B55 already express highest 20% of both CD8 and CCR7, one possibility is that
cells inside B55 are naïve CD8+ T cells. Indeed, cells in B55 agrees well with manually gated
naïve CD8 cells (S9 Fig and Figure A in S10 Fig) on single cell level. In addition, when compar-
ing the expression of CD45RA and CCR7 between cells in B55 and manually gated CD8 naïve
and memory cell types we find that cells in B55 match well with naïve cells for young donors
with slightly higher variation on CD45RA (Fig 4D). Cells in B55 express higher variation in
CD45RA for older donors, which is expected since box B55 was selected without expression
information of CD45RA (Fig 5E). Together, these results suggest that cells inside box B55
resemble naïve CD8+ T cells. Decreasing of naïve CD8+ T cells with ageing is a well-known
observation in immunology [40] and is also identified in this dataset (Figure B in S10 Fig). In
addition, we found that the abundancy of effector memory (TEM) and effector memory RA+
(TEMRA) CD8+ T cells are increased in old donors, as suggested by the increased percentage
of cells in B51 (CD8high CCR7low) (S11 Fig).
Distinction between naïve and memory CD8+ T cells is blurred in old donors. Next, we
analyzed cells inside box B52 (CD8highCCR7intermediate/low). The percentage of cells inside
box B52 (Fig 5A) was found to be increased in the old group (Fig 5B, p value << 0.001). Simi-
lar to box B55, the MFI of cells in box B52 for all samples were at similar levels for most mark-
ers, indicating a homogeneous cell subset is identified among all donors (Fig 5C). Notice that
box B52 lies in between two peaks (Fig 5A) which is a region often neglected or assigned to
one of the peaks by manual gating, and we have shown above that cells in peak above B52 (i.e.
B55) resemble naïve CD8 T cells and cells in peak below B52 (i.e. B51) resemble memory CD8
T cells (TEM and TEMRA). We hence infer that cells in B52 are transition cells between naïve
and memory cells which increases with ageing. Fig 5D and 5E show how cells in B52 locate rel-
ative to manually gated naïve and memory CD8 T cells.
CD4 versus CD8. Next, we applied our method to a mass cytometry dataset that originally
aims to identify immune signatures among 8 types of human tissues: cord blood, PBMC, liver,
spleen, skin, lung, tonsil and colon [35]. There are in total 35 samples, 3 to 6 samples for each
type of tissue (see Methods). The marker panel used for mass cytometry contains 41 markers
CytoBinning: Immunological insights from multi-dimensional data
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with a focus on the function (cytokine expression) of T cells (a full list of all 41 markers can be
found in supplementary information and [35]). Instead of differentiating the 8 types of tissues,
here we tried to classify CD4+ cells from CD8+ cells in all types of tissues. This is a good test for
our method since there exists great within-group variance (different tissues) in the two groups
we’re comparing, and we aim to find patterns that are consistent / similar across all types of tis-
sues but are significantly different between CD4+ and CD8+ cells. Like the previous dataset, we
divide these tissue samples into training and testing sets as well. From the 35 CD4 samples, 5
samples are randomly selected to be cross validation set; and the same was done for the 35
CD8 samples separately. Since there are in total 60 samples in training set (30 for each cell
type), the number of bins to use is 5 (Fig 3B). We identified 7 pairs of markers that were able
to classify CD4+ and CD8+ cells with 100% accuracy for both training and cross validation
datasets. Only 1 marker pair (CCR10 vs. CCR9) out of the 7 contains purely trafficking mark-
ers. This indicates that CD4+ and CD8+ T cells can be more easily differentiated by their func-
tion and lineage markers than trafficking markers, which is consistent with the results in the
original paper [35]. We selected one of the seven marker pairs: Interleukin (IL)-2 vs. CD25 to
show in Fig 6. The pattern formed by CD4 cells is distinct from CD8 cells in that CD4 cells
express significantly more IL-2 and slightly more CD25 in all types of tissues, which agrees
with previous findings based on circulating immune cells [41]. In addition, we found that per-
centage of cells in box B13 (red shaded region in Fig 6, IL-2 low and CD25 intermediate) is sig-
nificantly higher in CD8 cells, which is a subtle difference that would be missed by algorithms
based on a peak finding.
Discussion
The complexity of cytometry data has increased significantly in the last few years due to the
advancement in experimental techniques that enable measurements of dozens of parameters
on each cell for millions of cells [9]. Novel analysis algorithms are being introduced at a rapid
pace to deal with this data deluge that identify clusters of cells and project the high dimensional
information graphically in innovative ways. However, many biomedical researchers and clini-
cians do not (yet) have the intuition to interpret the novel graphic representations and trans-
late them into hypotheses and actions. There is also the flaw that nearest neighbors are not
meaningful in high dimensions, which is a phenomenon referred to as the “curse of
dimensionality” [33,34]. Here we introduce a simpler, alternative approach we term CytoBin-
ning. Our analysis approach combines automation of a more traditional workflow (as advo-
cated in [34]) and machine learning which links the high dimensional data back to two
biomarkers which can be represented as 2D scatter plots. The 2D scatter plot outputs are
designed to be directly interpretable by biomedical researchers and clinicians, who have an
established intuition for the meaning of these graphics. Thus, we are able to leverage their
existing expertise in interpreting these kinds of scatterplots. When the differences in pheno-
type are small, CytoBinning is able to further focus the researcher or clinician’s attention by
identifying, which specific regions of the scatter plot exhibits the most notable differences
between two groups of donors, allowing subtle shifts in the immune phenotype to be
highlighted.
Fig 4. Naïve CD8+ T cells were identified by our method as significantly decreased in old donors using only two
markers: CD8 and CCR7. (A) An example showing scatter plot of CD8 vs. CCR7 with box B55 highlighted. (B) Boxplot of
cell percentage inside box B55 between the two groups of donors. Each dot is a donor. (C) Scatter plot of mean fluorescent
intensity (MFI) of each donor, each point shows a donor (purple: young, orange: old). (D) & (E) MFI of CD45RA vs. MFI of
CCR7 for cells in B51, naïve and memory CD8 T cells. Each symbol shows a donor (young donors in D and old donors in
E), vertical and horizontal error bars show standard deviation of CCR7 and CD45RA intensity respectively.
https://doi.org/10.1371/journal.pone.0205291.g004
CytoBinning: Immunological insights from multi-dimensional data
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In contrast to automated gating methods that focus on the exact position of density peaks
or the number of groups formed by cells, CytoBinning doesn’t estimate the probability density
distribution of cells, and thus its findings are not limited to regions with high cell density or
sensitive to shifts in calibration. Instead, it extracts the pattern of 2D dot-plots and represents
it with a sequence of cell percentages. This enables the comparison across samples measured in
different experiments (given the markers are the same and they are measured in the same
channel respectively). In addition, CytoBinning doesn’t require any a priori biological under-
standing to guide the path of analysis. Conversely, it provides a list of important marker pairs
and related important cell sub-regions for biological researchers to subsequently interrogate.
In the first public dataset we analyzed, which compares lymphocyte populations in old and
young healthy donors, CytoBinning automatically discovered a decrease of naïve CD8+ T cells
in the elderly, a well-known yet subtle phenotype. In addition, CytoBinning identified a region
in the scatterplot of relatively low cell density between two well-established cell clusters which
is clearly increased with ageing as a new area of interest for the biological researcher. Two
markers (CD8 and CCR7) are sufficient to pinpoint this subset of cells which resides between
naïve and memory CD8+ T cells, and is not associated with a local peak in cell density in the
scatterplot. Such an area would be missed by both manual gating and density-based algorithms
which focusing exclusively on peaks in density.
The second public dataset we analyzed was even higher dimensional, based on mass cytom-
etry from eight types of human tissues. CytoBinning analysis of CD4+ vs. CD8+ T cells auto-
matically discovered higher expression of IL-2 in CD4+ T cells as we would expect [41], and
shows that this overexpression is consistent throughout all eight types of human tissues stud-
ied. In addition, CytoBinning correctly identified that CD25 is also more highly expressed in
CD4+ T cells [41]. This difference in CD25 and IL-2 was consistent among all types of tissues,
which is known and therefore obvious to a biological researcher. However, it also demon-
strates the power of our method as this marker pair was re-discovered without prior knowl-
edge from a heterogeneous dataset incorporating 35 samples from 8 different tissues, each
labelled with 41 markers. Hence, in addition to avoiding the pitfalls of density-based
approaches, when applied to very high-dimensional datasets CytoBinning is able to select the
salient markers which discriminate between groups of samples.
In summary, CytoBinning as a robust, automated approach to analyze high throughput
cytometry data presented in familiar and interpretable 2D scatter plots. While simultaneous
assessment of all markers is an important vision and challenge, in the interim there is a need to
facilitate interpretation of high-dimensional data given the evident gap between our techno-
logical ability to acquire this information and our ability to understand it. CytoBinning fills the
void between conventional manual analysis and complex automated analysis to extract deep
content in scatterplots which can be later cascaded into more complicated clustering or classi-
fication algorithms to obtain novel biological insights. This has particular potential value in
clinical and biological research settings where high-dimensional data is increasingly available
and commonly not fully understood. CytoBinning is able to identify the most important mark-
ers, while also highlighting novel cell populations that distinguish comparator datasets even if
these are to be found in areas of low cell density. Hence, it is a practical analysis approach with
Fig 5. An intermediate cell region which is often neglected by gating methods is identified as significantly increased in
old donors. (A) An example of scatter plot of CD8 vs. CCR7 with box B52 highlighted. (B) Boxplot of cell percentage inside
box B52 between the two groups of donors. Each dot is a donor. (C) Scatter plot of mean fluorescent intensity (MFI) of each
donor, each point shows a donor (purple: young, orange: old). (D) & (E) MFI of CD45RA vs MFI of CCR7 for cells in B52,
naïve, and memory CD8 T cells. Each symbol shows a donor (young donors in D and old donors in E), vertical and horizontal
error bars show standard deviation of CCR7 and CD45RA intensity respectively.
https://doi.org/10.1371/journal.pone.0205291.g005
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Fig 6. Patterns formed by IL-2 vs CD25 is distinct between CD4 and CD8 cells. One randomly chosen sample for each tissue is shown. The same sample for each type
of tissue is chosen to illustrate both CD4 and CD8 cells. Percentage of cells in the red shaded box (B13: IL-2 negative and CD25 intermediate) is significantly higher in
CD8 cells comparing to CD4 cells. Cells inside box B13 also express CD45RA, TNFα, and CD127 (S12 Fig).
https://doi.org/10.1371/journal.pone.0205291.g006
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potential to fill the complexity gap in interpretation of high-dimensional data in a wide range
of biomedical and clinical settings.
Methods
Platforms
The data analysis in this paper was conducted using R (version 3.1.1), with packages kernlab
for SVM; flowCore for logicle transformation of fcs files, and e1071 for multiclass SVM classi-
fication. All plots in this paper are created using ggplot2 package except for heatmaps which
are created with heatmap.2() function in gplots package. flowJo v10 was used for manually pre-
processing (compensation and live cell gating) fcs files in dataset 1.
Binning
The binning we used in our method has been previously proposed to estimate mutual informa-
tion (MI) [36]. Given bin number b, equally populated bins are drawn based on single cell
expression of marker A and marker B independently. These bins are then overlaid on each
other so that a grid is formed with b2 regions (boxes). Percentage of cells inside each box is
then an estimation of the joint probability P(Ai, Bj), where i and j are the corresponding bins
this box locates at. For a random distribution where marker A and marker B is not correlated
in any way, P(Ai, Bj) should be approximately the same in for every box. This is not true if
marker A and marker B is related in any way (i.e. their mutual information is not zero, this
relationship can be both linear and nonlinear). We use all P(Ai, Bj)s as a coarse-grained repre-
sentation of the point pattern between single cell expression of marker A and marker B. (Fig 1)
In our method this binning is done for every pair of markers.
Determine appropriate number of bins
We deduced a relationship between the maximum number of bins with zero false positive rate
(FPR) and the number of samples used in classification using our synthetic data. The relation-
ship we found is:
maximum number of bins ¼ roundð
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
number of training samples=2
p
Þ
Thus, for a given dataset, an estimation of the number of bins to be used is achieved. In
addition, we estimate FPR as follows:
1. For a given number of bins, apply afore-mentioned binning method to one pair of markers.
Each sample is now represented by the vector of P(Ai, Bj).
2. Randomly divide all samples into two groups.
3. Apply SVM classification (ksvm function in R package ks, with linear kernel and C = 10)
on the randomly divided groups.
4. Repeat step 2 & 3 for 100 iterations, record the frequency when classification accuracy
achieved 100% in step 3.
5. Repeat step 1 to 4 for all marker pairs, calculate the mean frequency of one pair achieving
100% accuracy. This frequency is used as an estimation of FPR.
6. Repeat steps above for all numbers of bins.
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Log ratio transformation
The percentages of cells in each box obtained with CytoBinning is compositional as they add
up to 100. To get rid of this dependency, we divide the percentages by their median before tak-
ing log with base 2 for every sample and every marker pair.
Selecting important marker pairs
Once the number of bins is determined, we divide all samples into training set (about 80% of
total samples) and testing set (the remaining 20% of all samples). SVM is applied to training
set and classification boundary obtained for every pair of markers. We use the obtained classi-
fication boundary to predict the cross validation set. Pairs that reached 100% accuracy for both
training and cross validation datasets are chosen as important marker pairs.
Selecting important boxes
We combined boxes formed by all selected marker pairs and applied statistical test (non-
parametric Mann-Whitney U test) for percentage of cells in each box. We then corrected the p
values for multiple comparison with Bonferroni correction, and boxes with p value<0.001
after correction are selected as important boxes. Important marker pairs selected above with-
out any important boxes are eliminated from the important marker pair list.
Dataset 1: Comparing old and young healthy PBMCs
Overview of samples. This dataset is published in reference [21] and downloaded at Flow
Repository (http://flowrepository.org) website [42]. These samples were processed in two experi-
ments, with 19 samples from young donors and 20 samples from old donors processed in the first
experiment, and the remaining samples processed in the second experiment. The panel of mark-
ers were kept the same for both experiments. In total, 16 markers are measured: Ki67, CD95,
CD127, CD57, CD3, CD45RA, CD8, CD14, CCR4, CD27, CD11b, PD-1, CD4, CD28, CCR7 and
a viability dye (live/dead). Details of sample storage and processing can be found in [21].
Pre-processing. Downloaded FACS files were first compensated based on the spill matrix
in the fcs files, and then manually gated to get live cells (S4 Fig). Logicle transformation was
performed with w = 0.5, t = 262144, and m = 4.5 using logicleTransform function in flowCore
package with R.
Dataset 2: Comparing CD4 and CD8 T cells in various types of tissues
The dataset used for demonstration was first published in [35] and downloaded from flow
repository website (https://flowrepository.org/) [42]. Tissue types, number of samples, and the
Table 1. Summary of sample information.
Tissue type Number of samples Reason for surgery
Cord Blood 5 Healthy donation at neonate
PBMC 4 Healthy donation
Tonsil 5 Tonsillar Hypertrophy
Spleen 3 Splenectomy (Due to Distal Pancreatomy)
Colon 6 Routine Colonoscopy
Skin 5 Abdominalplasty or Mastectomy—Invasive Ductal carcinoma
Lung 4 Lung cancer resection
Liver 3 Liver transplantation
https://doi.org/10.1371/journal.pone.0205291.t001
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reason for surgery are listed in Table 1. Immune cells were isolated from collected tissues and
cryopreserved. They were then thawed and washed for mass cytometry experiment. Two pan-
els of antibodies were used for staining, each containing 41 markers. The two panels were
named as “Function” and “Traffic” according to the antibodies included in it. We only used
function panel in this paper. Details of experimental process and the lists of antibodies can be
found in [35]. The downloaded samples from flow repository are FACS files, pre-gated to
major immune types (e.g. CD4, CD8, NKT, etc.). We used only CD4 and CD8 cells. We per-
formed logicle transformation using logicleTransform in R package flowCore, with parameters
w = 0.25, t = 16409, m = 4.5, and a = 0 according to [35]. The logicle transformed data were
then saved as text files for further analysis.
Supporting information
S1 Fig. Scatter plots of simulated point patterns. First two rows show point pattern A, the
lower two rows show point pattern B. Two major clusters in both point pattern A and B are
generated from the same distributions. The third cluster of point pattern A, located on center
right, consists about 10 to 20% of total cells. The third cluster of point pattern B, located at
upper left of all points, contains only 2 to 5% of all cells.
(TIF)
S2 Fig. Heatmap for percentage of cells inside each boxes with 6 bins. Percentage of cells in
box B16 (which corresponds to the third cluster in point pattern B) is significantly different
(adjusted p value = 0.0004) between these two point patterns. This is not seen with only 3 bins.
However, with 20 samples, analysis results using 6 bins is not reliable. Hence, in order to iden-
tify fine difference, more samples are needed.
(TIF)
S3 Fig. With 6 bins, both differences between pattern A and pattern B can be found by
CytoBinning. a) Example for both pattern A and pattern B. b) Heatmap showing hierarchical
clustering for CytoBinning results with 6 bins. Highlighted are the most different boxes
between pattern A and B (adjusted p value<< 0.001 for all three boxes).
(TIF)
S4 Fig. Illustration of manual gating strategy to get live cells.
(TIF)
S5 Fig. Select important marker pairs for the first dataset (old vs young). Ten samples are
randomly selected as cross validation dataset (4 in young group and 6 in old group). SVM clas-
sification was used to separate old and young samples with binning results for each marker
pair separately. Two marker pairs are able to achieve 100% classification accuracy for both
trainning and cross validation dataset (CD4 vs CD3 and CD8 vs CCR7).
(TIF)
S6 Fig. Ilustration of box B25 formed by CD4 and CD3. a) Position of box B25. b) Percent-
age of cells in B25 is higher in young donors (adjusted p value = 0.03). c) Scatter plot of mean
flourescent intensity (MFI) for all donors and all markers. This suggests cells in B25 are CD3+,
CD8+ and CD45RA+. d) An example showing how cells in B25 (green) compare to manually
gated naïve CD8 cells. e) Cells in B25 are divided into two groups: CCR7+ (expression of
CCR7>1) and CCR7- (expression of CCR7<1). The boxplots show that difference of cell per-
centage between old and young donors in B25 is driven by CCR7+ cells (p value << 0.001).
(TIF)
CytoBinning: Immunological insights from multi-dimensional data
PLOS ONE | https://doi.org/10.1371/journal.pone.0205291 October 31, 2018 15 / 19
S7 Fig. Ilustration of box B55 formed by CD4 and CD3. a) Position of box B55. Cells in B55
express the highest 20% of both CD3 and CD4. Hence they might be CD4 T cells. b) Percent-
age of cells in B55 is higher in old donors (adjusted p value = 0.05). c) Scatter plot of mean
flourescent intensity (MFI) for all donors and all markers. It suggests cells in B55 might be
CD8-, CCR7+ and CD45RA+.
(TIF)
S8 Fig. Ilustration of box B22 formed by CD4 and CD3. a) Position of box B22. b) Percent-
age of cells in B55 is higher in old donors (adjusted p value = 0.02). c) Scatter plot of mean
flourescent intensity (MFI) for all donors and all markers. It suggests cells in B22 might be
CD11b+, CD14+ and CD45RA+.
(TIF)
S9 Fig. Ilustration of manual gating strategy for naïve and memory CD8 T cells.
(TIF)
S10 Fig. a) Overlay of cells in B55 on manually gated CD8 naïve and memory cell types for
one donor. b) Boxplot of manually gated naïve CD8 cell percentage in live cells.
(TIF)
S11 Fig. Ilustration of box B51 formed by CD8 and CCR7 (CD8high CCR7low). a) Position
of box B51. b) Percentage of cells in B51 increased in old donors (adjusted p value = 0.01). c)
Scatter plot of mean flourescent intensity (MFI) for all donors and all markers. d & e) MFI of
CD45RA vs MFI of CCR7 for cells in B51, naïve and memroy CD8 T cells. Each symbol shows
a donor (young donors in d and old donors in e), vertical and horizontal errorbars show stan-
dard deviation of CCR7 and CD45RA intensity respectively.
(TIF)
S1 List. Markers measured in CD4 vs CD8 dataset.
(PDF)
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